Cell Therapy Manufacturing conference examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale. To ensure ..
the safe and rapid production of cell-based therapies, companies must develop robust, scalable and well-characterized processes and products in line with reguatory expectations. Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the technical requirements facing the production and analysis of cell-based therapies, supported by unpublished, in-depth case studies from leading industry and academic establishments. Topics incldue analytical development, CMC strategies, target product profiles, critical quality attributes, critical process parameters, process development and manufacturing. All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.